Issue 24 | 2016
Get instant access to latest e-book

latest newsRead more...

02

Jul 2016

AstraZeneca sells two dermatology drug rights to LEO Pharma

British drugmaker AstraZeneca Plc said it sold the rights to develop an experimental midstage drug to treat atopic dermatitis to privatelyheld LEO Pharma LEO Pharma would pay AstraZeneca million in upfront payment and billion in milestones However AstraZeneca will retain rights to devel..

02

Jul 2016

UK drugs regulator to halt approvals for Indian clinical trials firm

The UKs healthcare regulator has decided to suspended marketing approval for a widely used antibiotic that had won clearance based on clinical trials conducted by Indias Quest Life Sciences due to concerns over the integrity of trial data The Medicines and Healthcare products Regulatory Agency MHRA might also deny other pending drug approval reque..

01

Jul 2016

Exosome Diagnostics Enters Partnership with Takeda Pharmaceuticals

Exosome Diagnostics Inc the worlds only provider of an exosome liquid biopsy platform to monitor disease biomarkers in patient blood with the goal of reducing or eliminating the need for tissue biopsies has entered into a collaboration with Takeda Pharmaceuticals International Co to develop an exosomal RNA sequencing p..

01

Jul 2016

Ligand Receives $4 Million from Expansion of Two OmniAb® License Agreements

Ligand Pharmaceuticals Incorporated announces that two recent events relating to its OmniAb platform generated million in combined payments due to Ligand One event relates to a current OmniAb licensee exercising its option to expand access to the OmniAb platform and the second event relates to Wuxi sublicensing Chines..

eventsRead more...

03 - 06

Jul 2016

ECHC 2016 XXVII European Colloquium on Heterocyclic Chemistry

LD Organisation
Amsterdam, The Netherlands

06 - 08

Jul 2016

RICT 2016

LD Organisation
Caen, France

02

Jul 2016

Citius Pharmaceuticals Discontinues Suprenza™ To Focus on Core Assets

Citius Pharmaceuticals Inc a specialty pharmaceuti..

01

Jul 2016

CPhI China Report launched at CPhI China 2016

China forecasted as the fastest growing biologics ..

TOP ARTICLES

knowledge bank

  • interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen, Ph.D. is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging. He frequently presents on international conferences on subjects related to elastomeric and aluminium/plastic closures for pharm..

  • Articles

    The Unknown Sources of Error in the Pharmaceutical Weighing Process

    PROCESS WEIGHING AND RECORDING BY OBSERVATION This is the process flow for weighing the reference standard where the values are recorded by observation from the balance screen and written into a laboratory notebook by an analyst The subsequent calculations are performed using a handheld calculator with the results also written directly into the analysts laboratory notebook The volumetric flask i..

editorial Section

  • Competing on Alignment

    SWOT is both the most powerful and least understood strategic management tool Used correctly it translates the outputs of many other market analyses into a small number of key issues..

  • Future Trends in Ion Channel and Solute Transporter Drug Discovery

    Gene family members of the ion channel and solute transporter SLC families represent both historical targets of pharmaceutical significance and serve as exciting opportunities for current and future therapeutic development The common property of ion movement for many of the SLCs lends itself to considering platforms used in ion channel research to enable early drug discovery In addition the convergence of advances in both genetic analysis and assay technology bodes well for the identification of the next generation of ion channel and transporterbased drugs in the near future..

  • Issues & Concerns in Conducting Clinical Trials in India

    Issues like approval delays deficiencies of functioning of CROs and other stake holders liabilities and compensation to injured subjects insurance issues etc still remain in India which has made multinational companies to rethink on opting for India to conduct clinical trials in India recently There is a need for a law to ensure that the people who undergo clinical trials are not exploited and should be well informed about risk as well to provide..

  • Innovation Challenges in Manufacturing

    Most firms in the pharmaceutical industry think globally to expand demand for their products There are amenities from which firms leverage to launch a strategy to gain global market share These amenities include the regulatory dimension which helps reassign resources within and outside the firm..

  • Quality by Design

    The article presents a novel approach to applying Quality by Design QbD principles to the development of analytical methods Common critical parameters in HPLC gradient time temperature pH of the aqueous eluent and stationary phase are evaluated within the Quality by Design framework It is useful for the robust analytical method development and Design Space optimisation..

  • Peptides Remain a Growth Story

    Cloud solutions offer immediate returns in improving operational performance and reducing costs Multiple approaches to cloud solutions will be needed to satisfy life science industry needs complicating the development of a coherent cloud strategy..

TOP